Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.
about
Local order in the unfolded state: conformational biases and nearest neighbor interactionsAssembly of a polytopic membrane protein structure from the solution structures of overlapping peptide fragments of bacteriorhodopsin.The complete Consensus V3 loop peptide of the envelope protein gp120 of HIV-1 shows pronounced helical character in solutionCrystal structure of a human immunodeficiency virus type 1 neutralizing antibody, 50.1, in complex with its V3 loop peptide antigenConformation of thymosin beta 9 in water/fluoroalcohol solution determined by NMR spectroscopyThe role of a beta-bulge in the folding of the beta-hairpin structure in ubiquitinStructure and dynamic properties of membrane proteins using NMR.3D structure model of the principal neutralizing epitope of Minnesota HIV-1 isolate.Dual spatial folds and different local structures of the HIV-1 immunogenic crown in various virus isolates.Conformational preferences of the HIV-1 principal neutralizing determinant.Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates.Conformational model for the consensus V3 loop of the envelope protein gp120 of HIV-1 in a 20% trifluoroethanol/water solution.A putative role for platelet-derived PPARγ in vascular homeostasis demonstrated by anti-PPARγ induction of bleeding, thrombocytopenia and compensatory megakaryocytopoiesisNuclear magnetic resonance analysis of solution conformations in C4-V3 hybrid peptides derived from human immunodeficiency virus (HIV) type 1 gp120: relation to specificity of peptide-induced anti-HIV neutralizing antibodiesAn optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120The role of alpha-, 3(10)-, and pi-helix in helix-->coil transitions.Disorder and order in unfolded and disordered peptides and proteins: a view derived from tripeptide conformational analysis. I. Tripeptides with long and predominantly hydrophobic side chains.Synthetic peptide vaccine and antibody therapeutic development: prevention and treatment of Pseudomonas aeruginosa.Covariation of mutations in the V3 loop of human immunodeficiency virus type 1 envelope protein: an information theoretic analysis.Structure of a malaria parasite antigenic determinant displayed on filamentous bacteriophage determined by NMR spectroscopy: implications for the structure of continuous peptide epitopes of proteins.Structure and polymorphism of HIV-1 third variable loops.Human immunodeficiency virus-1 gp120 V3 loop for anti-acquired immune deficiency syndrome drug discovery: computer-aided approaches to the problem solving.NMR studies of carbohydrates and carbohydrate-mimetic peptides recognized by an anti-group B Streptococcus antibody.The V3-directed immune response in natural human immunodeficiency virus type 1 infection is predominantly directed against a variable, discontinuous epitope presented by the gp120 V3 domainV3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability.Prediction of the secondary structure of HIV-1 gp120.Biological and conformational studies on analogues of a synthetic peptide enhancing HIV-1 infection.Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity.Energetics of β-turn formation in a mutant peptide YPGDV from influenza hemagglutinin: an MD simulation study.Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodiesDisorder and order in unfolded and disordered peptides and proteins: a view derived from tripeptide conformational analysis. II. Tripeptides with short side chains populating asx and β-type like turn conformations.Computational model of the HIV-1 subtype A V3 loop: study on the conformational mobility for structure-based anti-AIDS drug design.Structure and polymorphism of the principal neutralization site of Thailand HIV-1 isolate.Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine design.A disulfide-bound HIV-1 V3 loop sequence on the surface of human rhinovirus 14 induces neutralizing responses against HIV-1.Structural analysis of the envelope gp120 V3 loop for some HIV-1 variants circulating in the countries of Eastern Europe.Global and local structural properties of the principal neutralizing determinant of the HIV-1 envelope protein gp120.ω-Turn: a novel β-turn mimic in globular proteins stabilized by main-chain to side-chain C−H···O interaction.
P2860
Q26851842-6D98F4AC-15C5-4B94-AE28-D642646657EFQ27633379-15A89E4D-39DD-46E7-8058-187332A5EBE1Q27729741-0EE0EC60-F567-4E10-AE92-089EB5F3BCCCQ27731780-0532B444-B60A-4AD9-9358-93CE1C71A5C3Q27736100-FEC8F801-E631-4D43-8526-62B589ECA66DQ28359807-905B829E-D591-4896-885E-AF9D6AC14BFEQ30432371-5AE4F524-82DA-4F35-9113-ADDFB2BF8245Q30886684-2E0D76B0-E460-4D3F-88A3-D9D1F2BC5079Q30952700-28ECBA31-47FB-4F70-AA49-470D5F6DAE52Q31010762-2A61BF92-2187-44F1-918C-EDCB42D9D6F5Q31112947-8A14A2FF-1022-4DBE-B382-D25EEEAEAB9CQ31911259-FB71AE80-1D56-4716-9CC2-79FE7CE73204Q33392128-F3A0A1DA-3766-4D51-990A-7076A5B6D848Q33639792-C845F7A6-CF98-49B1-88F2-E650B55DF766Q33820645-4E034816-7E7B-4651-BF51-0D9660389240Q34199126-5BB03EF0-B4DE-4F0C-8629-659B1BFA810FQ34508241-40ECBE62-CEB7-4E69-8CBE-A4A65ED5D709Q35136110-C1E4261F-3F01-496F-A7EF-3C6955FF90FDQ36454330-D13F48A2-890D-48B9-98E0-40FC8F933970Q36640407-1FF6D09C-EB0C-4AE7-BE0E-6EC1CD57941AQ36798525-CF2457FC-1966-4FDC-8472-8A34A5989E9FQ38014473-0D0BF716-07ED-4F0B-A691-0D00B8495EC0Q38355497-3515EDD6-4F02-4980-A635-C67643F5100CQ39439112-2FEEAD13-F2D6-470D-88F0-3D15FD50008CQ40047131-6694A31A-D58E-49E0-A008-DC96462E76EBQ40941083-B5690019-D3FE-49F8-8F6F-09CB4615468FQ40988136-8D607E00-F553-497D-9C29-ED8A70DE85D7Q42031529-AC9A1444-E71C-4381-A8D2-64112409EB7EQ42265423-65B90933-0E62-4CA9-B5C5-80A0E4516F89Q42576275-55F3ABF5-2359-465C-977A-F2AE71D9EAD9Q43658168-3483CB31-55BB-4ECB-B812-E65E8F37BC0AQ44111505-9459FCB3-7B7B-4A49-8AE3-B92E0DDFA909Q44279032-033B218D-3941-487D-A308-FC958A0B9A35Q45361823-F96E66F8-7AE2-4B4B-BF3E-588C04DB678CQ46346522-C178CD4F-0521-4E0B-B122-7DA6BFBB0305Q47269444-31B95772-B40B-4E5E-AFF0-ECD378C183A6Q52216971-BB16338F-696C-4C0B-909D-5CEBA263F25BQ53393543-EFE39508-7C35-497A-857A-13177E8E881F
P2860
Solution conformational preferences of immunogenic peptides derived from the principal neutralizing determinant of the HIV-1 envelope glycoprotein gp120.
description
1991 nî lūn-bûn
@nan
1991 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@ast
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@en
type
label
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@ast
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@en
prefLabel
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@ast
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@en
P356
P1433
P1476
Solution conformational prefer ...... 1 envelope glycoprotein gp120.
@en
P2093
Chandrasekhar K
P304
P356
10.1021/BI00102A009
P407
P577
1991-09-01T00:00:00Z